Abstract Analysis of sleep for the diagnosis of sleep disorders such as Type-1 Narcolepsy (T1N)
currently requires visual inspection of polysomnography records by trained scoring …

Narcolepsy type 1 (NT1) is caused by a loss of hypocretin/orexin transmission. Risk factors
include pandemic 2009 H1N1 influenza A infection and immunization with Pandemrix®. Here…

Study Objectives To assess the test–retest reliability of the polysomnography–multiple sleep
latency test (PSG–MSLT) diagnostic classification and measures and to study the …

Narcolepsy type 1 and narcolepsy type 2 are central disorders of hypersomnolence.
Narcolepsy type 1 is characterized by excessive daytime sleepiness and cataplexy and is …

This article addresses the clinical presentation, diagnosis, pathophysiology and management
of narcolepsy type 1 and 2, with a focus on recent findings. A low level of hypocretin‐1/…

Relationships between symptoms of hypersomnolence, psychiatric disorders, and hypersomnia
disorders (ie, narcolepsy and idiopathic hypersomnia) are complex and multidirectional. …

Narcolepsy type 1 (NT1) is a chronic orphan disorder, caused by the selective and irreversible
loss of hypocretin/orexin (ORX) neurons, by a probable autoimmune process. Little is …

The orexins, also known as hypocretins, are two neuropeptides (orexin A and B or hypocretin
1 and 2) produced by a few thousand neurons located in the lateral hypothalamus that …

Objective: To validate the Narcolepsy Severity Scale (NSS), a brief clinical instrument to
evaluate the severity and consequences of symptoms in patients with narcolepsy type 1 (NT1). …

Objective To assess video‐polysomnographic (vPSG) criteria and their cutoff values for the
diagnosis of disorders of arousal (DOAs; sleepwalking, sleep terror). Methods One hundred …